Eagle Bay Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Eagle Bay Advisors's AMGN Position: Q3 2026 in Review
Eagle Bay Advisors increased its Amgen (AMGN) stake by 2.8% in Q3 2026, buying an estimated $13.6K and bringing the position to 1,267 shares worth $534K. The position accounts for 0.39% of the portfolio, ranked #55.
Eagle Bay Advisors first reported a position in AMGN in Q2 2021 and has held it in 22 quarters since. The position peaked at $590K in Q2 2022. 3,271 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Eagle Bay Advisors held 1,267 shares of Amgen worth $534K as of Q3 2026.
- Eagle Bay Advisors bought 34 Amgen shares in Q3 2026, an estimated $13.6K.
- Amgen made up 0.39% of Eagle Bay Advisors's portfolio in Q3 2026, its #55 holding.
- Eagle Bay Advisors first reported a position in Amgen in Q2 2021 and has held it in 22 quarters since.
- Eagle Bay Advisors's Amgen position peaked at $590K in Q2 2022.
- 3,271 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Eagle Bay Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.